Edition:
United States

Novogen Ltd (NVGN.OQ)

NVGN.OQ on NASDAQ Stock Exchange Capital Market

1.33USD
27 Mar 2017
Change (% chg)

-- (--)
Prev Close
$1.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,255
52-wk High
$2.67
52-wk Low
$1.37

Latest Key Developments (Source: Significant Developments)

Novogen says CFO Cristyn Humphreys will leave company
Thursday, 9 Mar 2017 05:42pm EST 

Novogen Ltd : Cristyn Humphreys, chief financial officer (CFO) at Novogen will leave Novogen later this month to assume a new role outside industry . Andrew Heaton, CEO of Novogen North America, will leave Novogen .Transition of CFO will be overseen by Kate Hill, formerly a partner at Deloitte, who currently serves as company secretary.  Full Article

Novogen awarded grant for novel drug discovery
Wednesday, 8 Feb 2017 05:37pm EST 

Novogen Ltd - :Novogen awarded grant of up to $3mln for novel drug discovery.  Full Article

Novogen submits IND application for Cantrixil
Thursday, 11 Aug 2016 07:00am EDT 

Novogen Ltd : Novogen submits Investigational New Drug (IND) Application to the U.S. FDA for Cantrixil(TM) in ovarian cancer .Expect to initiate Cantrixil IND study in last quarter of 2016.  Full Article

Novogen Appoints Dr James Garner as Chief Executive Officer
Wednesday, 9 Dec 2015 04:59pm EST 

Novogen Limited:Says appointment of Dr James Garner as Chief Executive Officer.Garner will take up the role on Feb. 1, 2016, at which time he will be appointed to the Board of Directors of Novogen.  Full Article

Novogen Ltd appoints Iain Ross as Acting CEO
Wednesday, 22 Jul 2015 07:00am EDT 

Novogen Ltd:Says appointment to Board of Iain Ross, an experienced multi-national pharmaceutical and biotechnology executive.Mr Ross, a former director of Novogen Limited will re-join Board with immediate effect and take on role of Acting Chief Executive until permanent appointment is made.  Full Article

Novogen Limited says resignation of CEO
Tuesday, 21 Jul 2015 07:41pm EDT 

Novogen Limited:says resignation of its Chief Executive Officer and Director, Dr Graham Kelly, effective July 22.  Full Article

Novogen appoints Iain Ross as acting CEO and re-appoints him to the board
Tuesday, 21 Jul 2015 07:41pm EDT 

Novogen Limited:Says appointment to the Board of Iain Ross, an experienced multi-national pharmaceutical and biotechnology executive.Says Ross, a former director of Novogen Limited will re-join the Board with immediate effect and take on the role of Acting Chief Executive until a permanent appointment is made.  Full Article

Novogen Ltd announces appointment of interim chairman
Tuesday, 30 Jun 2015 07:27pm EDT 

Novogen Ltd:Says that Ian M. Phillips, MNZM, has been appointed interim chairman of the company.  Full Article

Novogen Ltd's Anisina on track to enter clinic in 2016
Tuesday, 23 Jun 2015 08:33pm EDT 

Novogen Ltd:Says that its candidate cytotoxic chemotherapy drug, Anisina, has proved an effective anti-cancer agent in animals, result of which it now has been fast-tracked by the company to come into clinic.Says Anisina targets the cytoskeleton of cancer cells.Says this is same target of most widely used chemotherapy drugs in cancer, taxanes and vinca alkaloids.  Full Article

Novogen Ltd announces issue of shares
Wednesday, 3 Jun 2015 09:50pm EDT 

Novogen Ltd:Says issue of 56,674,514 shares pursuant to non- renounceable pro-rata entitlement offer described in the announcement released to ASX on April 21.Issue price is $0.30 per share.Shares were issued in order to provide sufficient funds to develop the company's drug pipeline and general working capital.  Full Article

More From Around the Web

BRIEF-Novogen says CFO Cristyn Humphreys will leave company

* Cristyn Humphreys, chief financial officer (CFO) at Novogen will leave Novogen later this month to assume a new role outside industry